RLMD
#3058
Relmada Therapeutics, Inc. - Common Stock
3.5 1 USD
+0.04%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+3.54%
Changement Mensuel
-22.52%
Evolution sur 6 mois
-53.07%
Changement Annuel
+77.27%
Clôture Précédente
3.3 9
Open
3.3 9
Low
3.3 2
High
3.5 3
Financials
2021
Current report, 16 Jul 2021
RELMADA THERAPEUTICS, INC. current report, 16 July 2021
8-K
Quarterly report, Q2 FY2021
RELMADA THERAPEUTICS, INC. quarterly report, Q2 FY2021
10-Q
Current report, 20 May 2021
RELMADA THERAPEUTICS, INC. current report, 20 May 2021
8-K
Quarterly report, Q1 FY2021
RELMADA THERAPEUTICS, INC. quarterly report, Q1 FY2021
10-Q
Current report, 23 Mar 2021
RELMADA THERAPEUTICS, INC. current report, 23 March 2021
8-K
Current report, 15 Mar 2021
RELMADA THERAPEUTICS, INC. current report, 15 March 2021
8-K
Current report, 15 Mar 2021
RELMADA THERAPEUTICS, INC. current report, 15 March 2021
8-K
Current report, 06 Jan 2021
RELMADA THERAPEUTICS, INC. current report, 06 January 2021
8-K
2020
Annual report, FY2020
RELMADA THERAPEUTICS, INC. annual report, FY2020
10-K
Current report, 31 Dec 2020
RELMADA THERAPEUTICS, INC. current report, 31 December 2020
8-K